Estramustine therapy in Chromogranin A-positive Prostate Cancer Patients. (CROSBI ID 487340)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Ahel, Zaky ; Kovačić, Ksenija ; Kraljić, Ivo ; Trnski, Davor ; Tarle, Marko.
engleski
Estramustine therapy in Chromogranin A-positive Prostate Cancer Patients.
Estramustine therapy was applied during 15 months to Stage D3 prostate cancer pts refractory on Mab with elevated CgA level. Successful treatment was achieved in 29% of pts with the mean response time 9.2 months. Estramustine was examined as an addition to docetaxel therapy.
prostate cancer; estramustine therapy; chromogranin A; bone scan
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
331-331-x.
2001.
objavljeno
Podaci o matičnoj publikaciji
Proceedings, 11th International Prostate Cancer Update
Crawford, E David
Denver (CO): Medical Education Collaborative
Podaci o skupu
11th International Prostate Cancer Update
predavanje
31.01.2001-04.02.2001
Vail (CO), Sjedinjene Američke Države
